AbCellera Biologics (ABCL) Debt Ratio (2020 - 2025)
Historic Debt Ratio for AbCellera Biologics (ABCL) over the last 6 years, with Q1 2025 value amounting to 0.01.
- AbCellera Biologics' Debt Ratio fell 8143.78% to 0.01 in Q1 2025 from the same period last year, while for Mar 2025 it was 0.01, marking a year-over-year decrease of 8143.78%. This contributed to the annual value of 0.01 for FY2024, which is 8247.63% down from last year.
- Per AbCellera Biologics' latest filing, its Debt Ratio stood at 0.01 for Q1 2025, which was down 8143.78% from 0.01 recorded in Q4 2024.
- Over the past 5 years, AbCellera Biologics' Debt Ratio peaked at 0.04 during Q2 2023, and registered a low of 0.01 during Q4 2024.
- For the 5-year period, AbCellera Biologics' Debt Ratio averaged around 0.02, with its median value being 0.02 (2021).
- Its Debt Ratio has fluctuated over the past 5 years, first soared by 11391.75% in 2022, then tumbled by 8247.63% in 2024.
- Quarter analysis of 5 years shows AbCellera Biologics' Debt Ratio stood at 0.02 in 2021, then skyrocketed by 64.96% to 0.03 in 2022, then rose by 18.22% to 0.03 in 2023, then crashed by 82.48% to 0.01 in 2024, then increased by 9.78% to 0.01 in 2025.
- Its Debt Ratio was 0.01 in Q1 2025, compared to 0.01 in Q4 2024 and 0.01 in Q3 2024.